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Chlamydia are obligate intracellular bacteria, characterized by a unique biphasic
developmental cycle. Specific interactions with the host cell are crucial for the bacteria’s
survival and amplification because of the reduced chlamydial genome. At the start
of infection, pathogen-host interactions are set in place in order for Chlamydia to
enter the host cell and reach the nutrient-rich peri-Golgi region. Once intracellular
localization is established, interactions with organelles and pathways of the host
cell enable the necessary hijacking of host-derived nutrients. Detailed information on
the aforementioned processes will increase our understanding on the intracellular
pathogenesis of chlamydiae and hence might lead to new strategies to battle chlamydial
infection. This review summarizes how chlamydiae generate their intracellular niche in
the host cell, acquire host-derived nutrients in order to enable their growth and finally exit
the host cell in order to infect new cells. Moreover, the evolution in the development of
molecular genetic tools, necessary for studying the chlamydial infection biology in more
depth, is discussed in great detail.
Keywords: Chlamydia, internalization, pathogen–host cell interactions, inclusion membrane proteins, vesicular
pathways, non-vesicular pathways
INTRODUCTION
Chlamydiae are known for their unique biphasic life cycle during which they alternate between
two morphological forms: infectious extracellular elementary bodies (EBs) and metabolically active
intracellular reticulate bodies (RBs). It is clear that multiple membranes have a key function in the
chlamydial developmental cycle (Figure 1). In order to enter the host cell, naked EBs must surpass
its plasma membrane. Therefore, they attach to the host cell membrane by means of bacterial
ligands and host receptors, and inject pre-packaged effectors inside the host cytosol which enable
invasion. During internalization of the EBs, a vacuole, called the inclusion, is formed in which the
EBs reside and promptly transform into RBs (Hackstadt, 2012; Hegemann and Mölleken, 2012;
Mehlitz and Rudel, 2013). Multiple EBs can bind and enter the same host cell, leading to multiple
inclusions inside this cell. For some species, like Chlamydia (C.) trachomatis, these inclusions
ultimately fuse by means of homotypic fusion, creating one large inclusion (Elwell and Engel,
2012; Hackstadt, 2012; Richards et al., 2013). The latter process is orchestrated by the inclusion
membrane protein (Inc) IncA and will be discussed in more detail later in this review (see “SNARE
proteins”). Metabolically active RBs quickly modify the inclusion membrane by means of early
effectors in order to prevent degradation of the inclusion and to enable transport of the inclusion
toward the microtubule-organizing center (MTOC) (Scidmore et al., 1996). When located at the
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FIGURE 1 | The chlamydial developmental cycle in light of membrane interaction. Chlamydiae are characterized by their unique biphasic life cycle in which they
alternate between two morphological forms: EBs and RBs. (a) At the start of infection, extracellular infectious EBs use bacterial ligands to bind receptors on the
surface of the host cell. The attachment subsequently enables internalization of the bacteria into a vesicle inside the host cell, called the inclusion. Internalization can
be both dependent or independent of actin but since the actin-dependent process has been studies more extensively, this is the one depicted in the figure. Herein,
EBs inject pre-packed T3SS effectors into the host cytoplasm as soon as contact with the host is established, leading to reorganization of actin and uptake of the
EBs. Next, the EBs, residing inside the inclusion, transition into RBs. RBs are metabolically active particles which are able to amplify through binary fission. (b) These
RBs immediately produce early effectors which modify the inclusion membrane in order to prevent lysosomal degradation. (c) Furthermore, the inclusion starts
traveling across microtubules away from the periphery and towards the microtubule organizing center (MTOC). (d) Once the inclusion reaches the nutrient-rich
peri-Golgi region, the pathogen hijacks host cell metabolites in order to support its own growth as well as the growth of the inclusion membrane, necessary to allow
room for the expanding RBs. Nutrients are obtained through specific interactions of the inclusion with multiple host cell organelles such as fragmented Golgi
mini-stacks, the ER, lipid droplets, peroxisomes, lysosomes, recycling endosomes, mitochondria, and multivesicular bodies (MVBs). (e) Finally, the expanded
inclusion fills up most of the host cell cytoplasm after which the RBs transition back to EBs. These then exit the host cell in order to infect new cells.
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nutrient-rich peri Golgi region, chlamydial mid-cycle gene
products further modify the inclusion membrane, enabling
selective interactions with cellular compartments and pathways
in order to hijack essential nutrients (Moore and Ouellette, 2014).
Since the chlamydial genome is substantially reduced (ca. 1 Mb,
encoding 895 open reading frames for C. trachomatis) and lacks
many metabolic enzymes, survival of the pathogen depends on
these interactions (Stephens et al., 1998). However, the inclusion
membrane forms a barrier between the pathogen and the host’s
nutrients, meaning that mechanisms for nutrient transport across
the inclusion membrane are also membrane-related processes
which are crucial to the survival of chlamydiae. Furthermore, RBs
multiply inside of the inclusion by means of binary fission and the
inclusion expands. The lipids that are needed for the expansion
of the inclusion membrane and the amplification of the RBs are
scavenged from the host (Hackstadt et al., 1995, 1996; Scidmore
et al., 1996; Wylie et al., 1997; Van Ooij et al., 2000; Carabeo et al.,
2003; Su et al., 2004). The proteins present in those membranes
are mostly Chlamydia-specific (Taraska et al., 1996). Finally, at
the end of their life cycle, RBs transition back into EBs in an
asynchronous manner after which these EBs exit the host cell in
order to infect new cells.
It should be mentioned that the survival and growth of
Chlamydia not only depends on the establishment of an
intracellular niche, from where it can hijack a myriad of
host cell nutrients, but also on the evasion of the immune
response. When successful, the latter phenomenon not only
saves the bacterium from clearance but also effectuates an
asymptomatic course of chlamydial infections. The employed
strategies differ between species since different chlamydial strains
infect various hosts with each their specific types of immune
responses. Several groups devoted their research on studying the
molecular mechanisms driving these immune evasion strategies.
For example, C. trachomatis was shown to paralyze the host
immune system by preventing the activation of polymorphic
nuclear leukocytes (Rajeeve et al., 2018), was proven to avoid
a human-specific, ubiquitin-mediated marking of the inclusion
for destruction (Haldar et al., 2016), to affect host antigen
presentation by increasing the presentation of self-antigen
and thereby decreasing the presentation of Chlamydia-derived
peptides (Cram et al., 2016; Pickering et al., 2017). Besides its
immune evasion strategies, Chlamydia has evolved an escape to
certain stressors by switching to a physiological state in which the
bacterium ceases to divide but remains viable, called persistence.
We would like to refer to Panzetta et al. (2018) and Chen
et al. (2019) who reviewed the molecular mechanisms Chlamydia
employs to counteract host innate immune defenses as well as to
establish persistence (Panzetta et al., 2018; Chen et al., 2019).
At present, the events occurring at the host plasma
membrane as well as at the inclusion membrane supporting the
internalization and nourishing of chlamydiae will be discussed
in more detail. It should be noted that since there are
significant species- and strain-specific differences in the way
that Chlamydia interacts with the host cell, data cannot always
be extrapolated to other Chlamydia species and caution should
be exercised (Valdivia, 2008). In addition, at the end of this
review, recent advances in the development of molecular genetic
tools, necessary for studying these chlamydial processes in more
depth, are discussed. By bundling all the recent data on the
chlamydial life cycle in light of membrane interactions as well as
on recently discovered advances in promising molecular genetic
manipulation techniques for Chlamydia, the authors aim to
assist scientists in identifying novel strong targets for Chlamydia
prophylactics and therapeutics.
CHLAMYDIAL TRANSPORT THROUGH
THE HOST CELL
Attachment
Differences between species in host- and tissue-tropism are
in part due to the diversity in binding and internalization
mechanisms. The attachment of Chlamydia to the host cell
is assumed to be a multistep process. The initial interaction
of C. trachomatis and C. pneumoniae EBs with the host cell
appears to be a reversible, low-affinity electrostatic interaction
(Heckels et al., 1976; Hatch et al., 1981) of the EB with host
heparan sulfate-like glycosaminoglycans (GAGs) (Zhang and
Stephens, 1992; Su et al., 1996). Examples of known EB ligands
to bind heparan sulfate GAGs are OmcB for C. pneumonia
(Mölleken and Hegemann, 2008) and C. trachomatis (Fadel and
Eley, 2008) and major outer membrane protein (MOMP) for
C. trachomatis (Su et al., 1996). Furthermore, by chemically
mutating Chinese hamster ovary (CHO) cells and next selecting
the clones that are resistant to chlamydial infection, the
group of Carabeo and Hackstadt discovered a previously
undescribed irreversible, temperature-dependent and heparin-
resistant binding step, occurring subsequent to the reversible
binding of C. trachomatis serovar L2 EBs to cell-surface heparan
sulfate. This binding step was proven to be crucial for L2
infection and moreover, to differentiate the lymphogranuloma
venereum (LGV) biovar (of which the L2 serovar is a member)
from the trachoma biovars (Carabeo and Hackstadt, 2001).
Moreover, Fudyk et al. (2002) complemented these results
and proved that specific mutations modify the infectivity of
C. trachomatis LGV differently compared to trachoma biovars or
C. pneumoniae. Furthermore, based on their results of infecting
mutated CHO cell lines with C. trachomatis serovars as well
as well as C. pneumoniae, they hypothesized that chlamydiae
utilize a common multistep internalization pathway with specific
requirements per species (Fudyk et al., 2002). In the meantime,
several bacterial adhesins and host receptors are identified which
are involved in the attachment of EBs to the host cell. These are
listed in Table 1 and depicted in Figure 2. Some binding partners
remain unidentified and probably more molecular interactions
will exist but aren’t discovered yet. Moreover, host Protein
Disulfide Isomerase (PDI), a component of the estrogen receptor
complex, is shown to have a dual function in the entry of
chlamydiae into the cell. On the one hand, cell-surface PDI-
mediated disulfide reduction allows entry and on the other hand
structural PDI allows attachment, independent of PDI enzymatic
activity. In the latter case, Chlamydia binds to a host protein
that is associated with PDI instead of binding directly to cell-
associated PDI (Abromaitis and Stephens, 2009). Furthermore,
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TABLE 1 | Overview of the binding partners, involved in the binding of EBs to the surface of host cell for specific chlamydial species.
Chlamydial adhesin Host receptor Species References
LPS Cystic fibrosis transmembrane conductance regulator (CFTR) C. trachomatis Ajonuma et al., 2010
MOMP (CT681) mannose 6-phosphate receptor / insulin-like growth factor receptor
2 (M6PR/IGFR2) via N-Man-Glyc
C. pneumoniae Puolakkainen et al., 2005
CT017 (Ctad1) Beta-1 integrin (ITGB1) C. trachomatis Stallmann and Hegemann, 2016
Pmp21 Epidermal growth factor receptor (EGFR/ERBB) C. pneumoniae Mölleken et al., 2013
Hsp70 3′sulfogalactolipid (3′SGL) C. trachomatis Mamelak et al., 2001
? Fibroblast growth factor receptor (FGFR) via Fibroblast growth
factor 2 (FGF2)
C. trachomatis Kim et al., 2011
? Platelet-derived growth factor receptor (PDGFR) C. trachomatis Elwell et al., 2008
? Ephrin receptor A2 (EPHA2) C. trachomatis Subbarayal et al., 2015
? Apolipoprotein E4 C. pneumoniae Gerard et al., 2008
All Pmps ? C. trachomatis Becker and Hegemann, 2014
Pmp6 ? C. pneumoniae Mölleken et al., 2010
Pmp20 ? C. pneumoniae Mölleken et al., 2010
FIGURE 2 | Schematic representation of the binding partners, involved in the binding of EBs to the surface of host cells. For C. trachomatis three complete binding
partners are identified: chlamydial LPS and host Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), chlamydial CT017 and host beta-1 integrin (ITGB1)
and chlamydial heat shock protein 70 (Hsp70) and host 3′sulfogalactolipid (3′SGL). Furthermore, several chlamydial adhesins or host receptors are known to be
involved in the attachment of C. trachomatis EBs to the host cell without knowing their binding partners: host Ephrin receptor A2 (EPHA2), Platelet-derived growth
factor receptor (PDGFR) and Fibroblast growth factor receptor (FGFR) (by means of Fibroblast growth factor 2 (FGF2) bridging) and all chlamydial polymorphic
membrane proteins (Pmps). For C. pneumoniae the identified binding couples to date are chlamydial Pmp21 and host Epidermal growth factor receptor (EGFR) and
chlamydial MOMP and host mannose 6-phosphate receptor (M6PR) (by means of N-Man-Glyc bridging). Host PDI is necessary for EB attachment to the cell but the
bacterium does not bind directly to the PDI. Instead, Chlamydia attaches to a host protein, associated with PDI.
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chlamydiae use the involvement of PDI in attachment and
invasion by controlling its activity in order to avoid re-infection.
When an infected cell gets re-infected during the replicative
phase of the RBs, the formation of EBs may be prevented.
C. trachomatis therefore induces the depletion of Glucose
regulated protein 96 (Gp96) from the infected cells during its
replicative phase, resulting in reduced activity of PDI on the cell
surface (Karunakaran et al., 2015).
As shown in Table 1 and Figure 2, all polymorphic membrane
proteins (Pmps) are involved in the attachment of C. trachomatis
to the host cell. The Pmp family is the largest protein family of
Chlamydia species and it is a unique feature of the genus (Horn
et al., 2004; Vandahl et al., 2004). Since the Pmps account for
3.15 and 5.1% of the total coding capacity of C. trachomatis and
C. pneumoniae, respectively (Grimwood and Stephens, 1999),
which is a relatively high proportion of the greatly reduced
genome, it is suggested that the Pmps might play an important
role in chlamydial biology. In silico predictions identify Pmps
as autotransporter (type V secretion system) proteins, based
on their cleavable N-terminal signal sequence for translocation
across the inner membrane, their central passenger domain
which provides the protein’s function, their β-barrel-shaped
C-terminal transporter domain and the phenylalanine at the
end of this domain, suggesting outer membrane localization
(Struyve et al., 1991; Henderson and Lam, 2001; Dautin and
Bernstein, 2007). Moreover, experimental evidence of this in silico
prediction has been generated for several Pmps (Longbottom
et al., 1998; Vandahl et al., 2002; Wehrl et al., 2004; Kiselev
et al., 2007; Liu et al., 2010). One of the functions of these
autotransported proteins is that of adhesin, as the conserved
motifs GGA (I,L,V) and FxxN were also found in adhesins
of Anaplasma phagocytophilum (Girard and Mourez, 2006).
Mölleken et al. (2010) showed that yeast cells, expressing
C. pneumoniae Pmp6, Pmp20 and Pmp21 (orthologs of PmpG,
PmpB and PmpD of C. trachomatis, respectively) on their surface,
and beads coated with recombinant proteins of these three Pmps
adhere to human epithelial cells. The observation that pre-
incubation of epithelial cells with these three proteins reduced
the binding significantly confirmed the adhesive capacities of
Pmp6, Pmp20, and Pmp21 of C. pneumoniae. Pmps appear to be
functioning as species-specific adhesins, as incubation of human
epithelial and endothelial cells with C. trachomatis Pmps was
not effective to block a subsequent C. pneumoniae infection and
vice versa, suggesting that Pmps are involved in host and tissue
tropism (Becker and Hegemann, 2014). The size and amino acid
sequences of the Pmps are highly variable. The number of Pmp
genes depends on the species (Vasilevsky et al., 2016), ranging
from 9 to 16 full length genes for the chlamydial reference strains
C. abortus S26/3 (Thomson et al., 2005), C. avium 10DC88
(Sachse et al., 2014), C. caviae GPIC (Read, 2003), C. felis FE/C-56
(Azuma et al., 2006), C. gallinacea 08-1274/3 (Sachse et al., 2014),
C. muridarum Nigg (Read et al., 2000), C. pecorum DBDeUG
(Bachmann et al., 2014), C. pneumoniae CWL029 (Kalman et al.,
1999), C. psittaci ATCC VR-125/6BC (Voigt et al., 2011), and
C. trachomatis D/UW-3/Cx (Stephens et al., 1998). Given the
fact that the family of Pmps is most probably a product of gene
duplications, enabling functional diversity, it is assumed that
these proteins are directly linked to the variations in disease
severity, observed between different strains (Abdelsamed et al.,
2013). For example, although Van Lent et al. (2016) observed
structural similarities between C. psittaci Pmps and therefore
suggested comparable functions, they identified C. psittaci PmpA
and PmpH as important players in pathogenesis. Moreover,
the apparent immunoaccessibility/antigenicity of these two
Pmps suggested their potential in vaccine design (Van Lent
et al., 2016). Gomes et al. (2006) studied polymorphisms in
the nine Pmps of all C. trachomatis serovars and delivered
evidence for the correlation of the identified genetic variations
with tissue tropism. More specifically, analysis of these
polymorphisms showed the strongest relation between the LGV
serovars, causing invasive urogenital diseases, who differed
the most from the ocular and non-LGV urogenital serovars.
Furthermore, phylogenetic reconstructions demonstrated that
for six of the nine Pmp genes, the serovars clustered based
on tissue tropism. Finally, they provided statistically significant
evidence for intergenomic recombination between Pmp genes,
possibly enabling evolutionary adaptations in tissue tropism and
pathogenesis (Gomes et al., 2006). Moreover, the group also
proved the differential occurrence of putative insertion sequences
among Pmps of different serovars, representing distinct disease
or prevalence groups (Gomes et al., 2004). Lastly, Jeffrey et al.
(2010) proved the correlation between polymorphisms in the
Pmp genes across C. trachomatis serovars and rectal tropism.
Thus, in conclusion, polymorphisms in Pmps relate to strain
distinction, tissue tropism and possibly disease severity.
Internalization
A myriad of research groups has devoted their resources in
studying the internalization of chlamydiae but despite all of
the data gathered over the years, still no consensus pathway
has been described and a lot of conflicting results were
published over the years. For example, there is still a controversy
about the contribution of clathrin-mediated endocytosis to the
internalization of chlamydiae (Hodinka et al., 1988; Wyrick
et al., 1989; Majeed and Kihlström, 1991). Microscopy studies
have both supported and invalidated the concept of receptor-
mediated endocytosis by clathrin-coated pits: although three
research groups observed association of C. trachomatis with
clathrin-coated pits and/or the uptake of C. trachomatis strains
into clathrin-coated vesicles (Hodinka et al., 1988; Wyrick et al.,
1989; Majeed and Kihlström, 1991), other researchers showed
that C. trachomatis entry was unaltered when clathrin-dependent
endocytosis was inhibited (Ward and Murray, 1984; Boleti et al.,
1999). The latter could be supported by the fact that conventional
clathrin pits measure 100 nm in diameter whilst chlamydial EBs
have an average size of 250 nm (Hybiske and Stephens, 2007).
Similarly, research on caveola-mediated entry has provided both
supporting (Norkin et al., 2001; Stuart et al., 2003; Webley et al.,
2004) and disproving (Gabel et al., 2004) evidence. Moreover,
studies provide evidence of Chlamydia entering the cell through
directed phagocytosis (Byrne and Moulder, 1978) as well as
through generalized pinocytosis (Reynolds and Pearce, 1990).
However, overall, investigations focused predominantly on
actin driven processes (Figure 3) whereat EBs carry a
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FIGURE 3 | Schematic representation of the signal transduction pathways, involved in the internalization of C. trachomatis EBs through phagocytosis. After
attachment of the EB to the host cell, activation of the T3SS takes place. The first T3SS effectors that get secreted are Tarp, CT166 and CT694. Tarp reorganizes
actin in a direct as well as in an indirect manner. The first mechanism reflects the fact that Tarp contains actin-binding domains and a proline-rich region, enabling
Tarp respectively to be a nucleator and to enhance actin bundling. The indirect process on the other hand is a Rac1-dependent mechanism. Host Src, Syk and Abl
kinases phosphorylate the N-terminal tyrosine-rich tandem repeats of Tarp, leading to the recruitment of several proteins. On the one hand ABI1 interacts with the
phosphorylated Tarp and complexes with SOS1 and EPS8. On the other hand, PI3K binds phosphorylated Tarp, producing PI(3,4,5)P3 and thus activating another
protein which also interacts with the phosphorylated Tarp, VAV2. Subsequently SOS1 and VAV2 activate Rac1, which next recruits WAVE2, ABI1, ARP2, and ARP3.
These actin regulators finally reorganize actin. Since Tarp-induced actin rearrangements are transient, it is believed that CT166 and CT694 regulate the actin
de-polymerization.
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functional type 3 secretion system (T3SS) through which,
upon attachment, they translocate pre-packaged effectors along
with their respective chaperones directly into the host cell
cytoplasm in order to induce the cytoskeletal rearrangements
(Peters et al., 2007; Saka et al., 2011). Prior to attachment
of chlamydiae to the host, the activity of this completely
assembled T3SS in EBs is prevented by means of disulfide
bonding within Secretion and cellular translocation protein
(Sct) F and SctC, both structural proteins of the T3SS, and by
means of positioning a CopN plug on the cytoplasmic face of
the T3SS. The mentioned CopN plug consists of a complex
of CopN with T3SS chaperones Scc1 and Scc4 N-terminally,
positioning CopN at the T3SS of EBs (Silva-Herzog et al.,
2011) and with additional chaperone Scc3 C-terminally, which
inhibits the secretion of CopN (Slepenkin et al., 2005; Ferrell
and Fields, 2016). Immediately after the EBs attach to the
host cell plasma membrane, the T3SS gets activated though the
secretion of CopN and deployment of translocator proteins CopB
and CopD. CopB and CopD then form the invasion-related
translocon that enables the transport of subsequently secreted
T3S effectors (Bulir et al., 2014, 2015; Ferrell and Fields, 2016).
Gene duplication were detected for CopB and CopD, called
CopB2 and CopD2. The group of Chellas-Géry et al. (2011)
compared CopB to CopB2 and showed that, although both
localize to the inclusion membrane, CopB2 was continuously
detectable whilst CopB was only detectable at some points during
the infection, being early on and 20 h post infection. Therefore,
one could argue the possibility of CopB mediating early and
late translocation whereas CopB2 functioning in the meantime
(Chellas-Géry et al., 2011).
The activated T3SS secretes invasion-related effectors,
effectuating the internalization process. In case of C. trachomatis,
translocated actin-recruiting phosphoprotein (Tarp), CT166 and
CT694 are secreted first (Pais et al., 2013; Chen et al., 2014).
Tarp is an early multidomain effector protein that mediates actin
nucleation and bundling. Two mechanisms are described by
which Tarp exerts its effects. Firstly, Tarp is in direct contact
with actin: on the one hand it is a nucleator, considering
it contains several C-terminal actin-binding domains with
similarity to WH2 domain proteins and on the other hand
it contains a proline-rich region that may enhance actin
oligomerization (Jewett et al., 2006). Secondly, Tarp enables
actin remodeling through a RAS-related C3 botulinum toxin
substrate 1 (Rac1)-dependent mechanism at the attachment
sites (Carabeo et al., 2004; Clifton et al., 2004). In the latter
scenario, host Src (Jewett et al., 2008), Syk (Mehlitz et al.,
2008), and Abl (Elwell et al., 2008) kinases phosphorylate the
N-terminal tyrosine-rich tandem repeats of Tarp, leading to the
recruitment of son of sevenless homologue 1 (SOS1) and VAV2.
Interaction between SOS1 and phosphorylated Tarp is mediated
through ABL interactor 1 (ABI1), which forms a multiprotein
complex with SOS1 along with epidermal growth factor receptor
kinase substrate 8 (EPS8). Activation of VAV2 on the other
hand is dependent on phosphatidylinositol-3,4,5-triphosphate
(PI(3,4,5)P3), produced by phosphoinositide 3-kinase (PI3K),
an enzyme also binding phosphorylated Tarp. SOS1 and VAV2
activate Rac1, which in turn recruits the actin regulators
Wiskott-Aldrich syndrome protein family member 2 (WAVE2,
also known as WASF2), ABI1, actin-related protein 1 (ARP2)
and ARP3. These regulators are essential for actin reorganization
(Carabeo et al., 2007; Lane et al., 2008; Jiwani et al., 2012; Mehlitz
and Rudel, 2013). The actin polymerization is accompanied by
extensive membrane remodeling. Actin rearrangements induced
by Tarp are transient and it is hypothesized that other effectors,
such as C. trachomatis CT166 (Thalmann et al., 2010) and CT694
(Hower et al., 2009) might regulate the actin de-polymerization.
Whereas C. trachomatis recruits only Rac1 and not Cdc42,
C. caviae has been show to use both in addition to Arf6 in order
to promote its entry (Subtil et al., 2004; Balañá et al., 2005). As
far as we know, the role of Arf6 during C. trachomatis infection
has not been examined yet.
Clifton et al. (2005) analyzed the genomes of C. trachomatis
serovar L2 and D, C. muridarum, C. caviae and C. pneumoniae
and discovered that each contained an ortholog of Tarp.
Moreover, no phosphotyrosine was detected at the site of
entry for the orthologs from C. muridarum, C. caviae and
C. pneumoniae. However, all of these orthologs contain at
least one and up to four functional C-terminal actin binding
domains and for each of the species, purified recombinant Tarps
were capable of nucleating actin filament formation in vitro
(Jewett et al., 2010). This indicates the dependence of actin
recruitment on the presence of the C-terminal domain of
Tarp and not necessarily on tyrosine phosphorylation (Clifton
et al., 2005). Moreover, phylogenetic analysis of Tarp from
C. trachomatis reference strains as well as ocular, genital and
LGV C. trachomatis clinical isolates resulted in a clustering
of LGV and ocular isolates, separated from a cluster formed
by the urogenital isolates. Also, LGV and ocular strains could
easily be distinguished based on the number of tyrosine-rich
repeats (up to nine for LGV strains whilst only one for ocular
strains) and the number of actin binding domains (two for
LGV strains whilst up to four for ocular strains) for Tarp. This
suggests that, besides the previously mentioned C. trachomatis
Pmps, also Tarp could plausibly play a role in C. trachomatis
adaptations to a specific niche within the host (Lutter et al.,
2010). Nevertheless, although the genes encoding Pmps and
Tarp, among others, have been shown to group C. trachomatis
serovars based on tissue tropism, classification of C. trachomatis
strains in serovars is not based on Tarp or Pmps but on MOMP.
MOMP is an immunodominant surface antigen which function
is on the one hand a porin in RBs (Bavoil et al., 1984) and on
the other hand a potential adhesin in EBs (Su et al., 1990; Su
and Caldwell, 1991). However, the phylogenetic categorization
of MOMP is not concordant with pathobiotypes or tissue
tropism of C. trachomatis (Stothard et al., 1998; Millman et al.,
2006). Therefore, analyzing other genetic variations between
the different C. trachomatis strains, aside of those present
in the gene encoding MOMP, might allow the identification
of new factors that enable specific tissue tropisms or disease
severity. However, since comparison of the complete genome
of an oculotropic isolate with a genitotropic isolate pointed out
a 99.6% identity (Carlson et al., 2005), it is clear that host
genetic differences will also influence chlamydial disease outcome
(Abdelsamed et al., 2013).
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Intracellular Transportation to the MTOC
The EBs are, immediately after entry, sequestered in the
inclusion. Remodeling of the inclusion membrane by insertion
of bacterial proteins quickly dissociates it from the endosomal
pathway, avoiding lysosomal fusion (Scidmore et al., 1996;
Scidmore et al., 2003). The remodeled membrane subsequently
promotes migration of the inclusion along microtubules to the
MTOC, nearby the peri-Golgi region (Scidmore et al., 1996;
Grieshaber et al., 2003). Localization to the MTOC facilitates
interactions with nutrient-rich compartments (Richards et al.,
2013). This transport is dynein-dependent and p50 dynamitin-
independent. However, it is incorrect to state that transportation
is dynactin-independent since some components of the dynactin
complex still get recruited (Hackstadt, 2012; Kokes and Valdivia,
2012). For example, Sherry et al. (2018) showed that dynactin
interacts with C. trachomatis Inc CT192 during infection and
is recruited to the inclusion membrane in a CT192-dependent
manner. p50 dynamitin usually links cargo to microtubules.
It is therefore suggested that chlamydial effector proteins in
the inclusion membrane mimic the cargo-binding activity in
order to tether the inclusion to dynein and/or centrosomes
(Grieshaber et al., 2003). C. trachomatis infection was shown
to increase activation of Src family kinases (SFKs) and these
SFKs were proven to be required for microtubule-dependent
trafficking of the inclusion to the MTOC and for intracellular
growth. Migration to the MTOC is absent in C. caviae
and C. muridarum, who do not recruit SFKs. Moreover, an
increase in inclusion development and bacterial growth when
inhibiting SFKs suggested that SFKs restrict growth of these non-
human strains (Mital et al., 2010; Mital and Hackstadt, 2011a).
C. trachomatis Incs (discussed in more detail in the section on
vesicular pathways) IncB (also known as CT232), CT101, CT222,
and CT850 reside in cholesterol-rich microdomains at the point
of centrosome–inclusion contact and colocalize with active SFKs
(Mital et al., 2010), making it likely that these Incs participate
in transport. For example, C. trachomatis CT850 directly binds
to dynein light chain 1 (DYNLT1) to enable the trafficking of
the inclusion to the MTOC (Mital et al., 2015) (Figure 4).
In case of C. psittaci, IncB has been shown to interact with
Snapin, which also binds dynein, thus connecting the inclusion
to the microtubule network (Böcker et al., 2014). Snapin is a
cytoplasmic host protein with a multivalent role in intracellular
trafficking (Lu et al., 2009).
Stabilizing the Inclusion Membrane
The inclusion membrane is extremely fragile, hence its only
recently successful purification (Aeberhard et al., 2015). In order
to preserve its integrity and structural stability, F-actin and
intermediate filaments encapsulate the inclusion in the form of
a dynamic scaffold (Kumar and Valdivia, 2008; Bastidas et al.,
2013). Since disruption of inclusion integrity leads to leakage of
inclusion contents into the host cytoplasm and a robust activation
of IL-8 expression, the cytoskeletal scaffold on the inclusion
could limit exposure of bacterial products to cytoplasmic
innate immune surveillance pathways (Buchholz and Stephens,
2008; Kumar and Valdivia, 2008). Recruitment and assembly
of F-actin takes place by means of RhoA GTPases (Kumar
and Valdivia, 2008), septins (Volceanov et al., 2014), EGFR
signaling (Patel et al., 2014), and CT813 (Kokes et al., 2015).
Kumar and Valdivia proposed a model wherein C. trachomatis
Incs recruit RhoA, which in turn triggers F-actin assembly.
F-actin next recruits and stabilizes intermediate filament proteins
through linker molecules, resulting in the formation of a stable
scaffold around the inclusion. The necessary flexibility of this
structure surrounding an expanding inclusion would then be
provided by CPAF, a chlamydial protease that progressively
cleaves the preassembled filaments without loss of their structural
function (Kumar and Valdivia, 2008). Additionally, microtubules
reorganize at the inclusion surface in order to create a
microtubule superstructure. However, since this superstructure
is responsible for the reorganization of Golgi mini-stacks, the
recruitment and assembly of this cytoskeletal scaffold will be
discussed in more detail in the section on chlamydial interaction
with the Golgi apparatus.
Furthermore, C. trachomatis inclusions show membrane
deformation and tubulation. Mirrashidi et al. (2015) showed that
this morphology was effectuated by IncE which recruited sorting
nexin (SNX) proteins SNX5 and SNX6. More specifically, the
C-terminal region of IncE interacted with the phox-homology
(PX) domains of SNX5 or SNX6 (Mirrashidi et al., 2015). These
SNX proteins provide a mechanistic link to tubulation, as they
are necessary and sufficient for membrane deformation and
tubule formation (Frost et al., 2009; van Weering et al., 2012).
Finally, Aeberhard et al. (2015) proved that the SNX protein
recruitment by C. trachomatis is not a means to enable bacterial
infections but rather to circumvent SNX protein-enhanced
bacterial destruction, since SNX proteins regulate endocytic and
lysosomal degradation. This statement was based on the fact
that RNAi-mediated depletion of SNX5/SNX6 did not slow
down infection but rather increased the production of infectious
C. trachomatis progeny (Aeberhard et al., 2015).
Release
Knowledge on the mechanism of chlamydial release from
infected cells is limited. Banks et al. (1970) proved in the year
1970 the induced lysis and concomitant host cell death by
egressing C. trachomatis of the LGV biovar and later, Todd and
Caldwell (1985) showed that the ocular and genital biovars of
C. trachomatis exit cells without associated death of the host cell.
In the year 2007 two research groups published a paper
on the release of C. trachomatis EBs from the host cell
(Beatty, 2007; Hybiske and Stephens, 2007). Remarkably,
both papers showed strongly contradictory conclusions. Beatty
complemented the aforementioned paper of Todd and Caldwell
(1985) by clarifying the mechanism of release. She showed
that the egression of C. trachomatis serovar E (thus a genital
biovar) was mediated by the expansion of the intracellular
bacterial inclusion, accompanied by the disruption of the
plasma membrane integrity. Exocytic fusion of the lysosomes
with the plasma membrane was promoted by the calcium-
induced actin depolymerization. She then also explained that
associated host cell death was avoided by a lysosomal-mediated
reparative process in which lysosomes are delivered to the plasma
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FIGURE 4 | Schematic representation of the intracellular transportation of the chlamydial inclusion toward the MTOC. Remodeling of the inclusion membrane
enables dynein-dependent migration of the inclusion along microtubules. C. trachomatis inclusion membrane protein CT850 can directly bind to DYNLT1 to promote
the positioning of the inclusion at the MTOC.
membrane. Importantly, this repair also supported chlamydial
persistency because of the retention of left-over bacteria within
the surviving host cell (Beatty, 2007). The second paper on
chlamydial egress from the host cell, published in 2007, was a
paper form Hybiske and Stephens. In this paper, two mutually
exclusive release methods were discussed: lysis and extrusion.
Lytic egress was described as a destructive mode of release,
proceeding by a temporally well-defined two-step process: first
the cysteine protease-dependent lysis of the inclusion vacuole,
followed by the rupturing of the host cell plasma membrane. The
latter process appeared to be regulated by intracellular calcium
signaling. Furthermore, Nguyen et al. (2018) identified an
interaction between the Inc MrcA and the Ca2+ channel inositol-
1,4,5-trisphosphate receptor type 3 (ITPR3) and proved through
mutagenesis and siRNA depletion studies that Ca2+ signaling
pathways are involved in the regulation of C. trachomatis
release. In contrast, extrusion represented the actin-dependent
package release of portions of chlamydial inclusions by means of
membranous protrusions. Both the original cell and the residual
inclusion would remain intact thus promoting persistence of
the infection. Hence, release of inflammatory content would be
prevented and EBs would be protected from host cell immunity.
The released EBs would finally reside in extracellular inclusion
bodies, surrounded by the actin cytoskeleton (Chin et al., 2012),
the host plasma membrane, and a thin layer of cytoplasm between
the plasma and inclusion membranes. Extrusion was proven to
be dependent on actin polymerization, neuronal Wiskott-Aldrich
syndrome protein, myosin II and RhoA. The latter specifically
regulated the final stage of extrusion, being the pinching off of
the inclusion body (Hybiske and Stephens, 2007). Furthermore,
results showed that survival of C. trachomatis was significantly
lower when infecting macrophages or DCs compared to epithelial
cells (Steele et al., 2004). However, the group of Hybiske has
proven that bone marrow macrophages as well as DCs engulf
extrusions and that subsequent survival of chlamydiae is hence
promoted by the lipid barrier surrounding them (Sherrid and
Hybiske, 2017; Zuck et al., 2017). Nevertheless, the engulfment of
extrusions initiated fast DC apoptosis and significantly modified
the transcriptional upregulation of biologically relevant DC
cytokines (Sherrid and Hybiske, 2017). Hybiske and Stephens
also claimed that both processes, extrusion and lysis, are prevalent
among genital as well as LGV biovars of C. trachomatis and
that they occur at nearly equivalent frequencies (Hybiske and
Stephens, 2007), thus objecting the papers of Banks et al. (1970)
and Todd and Caldwell (1985).
Recently, studies from Lutter et al. (2013) provided the
first insights into the regulation of egress mechanisms in
C. trachomatis. The group discovered the recruitment of MYPT1,
a subunit of myosin phosphatase, to the periphery of the inclusion
through interaction with inclusion membrane protein CT228,
an apparent central player in the regulation of egress. MYPT1-
mediated phosphorylation of myosin light chain II (MLC2)
favored extrusion, while the depletion or dephosphorylation of
MLC2 favored lysis (Lutter et al., 2013).
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The stability of the inclusion membrane depends on the
presence of an actin scaffold surrounding it. Hence, in order
to exit the host cells through lysis, chlamydiae must be able
to disassemble this scaffold. The group of Yang et al. (2015)
demonstrated that the cryptic chlamydial plasmid controls lysis.
They furthermore demonstrated that plasmid gene protein 4
(Pgp4), a transcriptional regulator of multiple chromosomal
genes, is essential for actin depolymerization prior to cell exit
and that Pgp4-dependent release is reliant on the chlamydial
T3SS (Yang et al., 2015). Furthermore, the previously discussed
chlamydial protease CPAF, cleaving intermediate filaments, is
believed to also be involved in chlamydial release, however, it is
not involved in actin depolymerization (Snavely et al., 2014).
THE ROLE OF INCLUSION MEMBRANE
ASSOCIATED PROTEINS IN FULFILLING
CHLAMYDIAL METABOLIC NEEDS
Inclusion Membrane Transport Proteins
The inclusion provides shelter to the bacteria by shielding them
from the host but on the other hand the inclusion membrane
also represents a metabolite barrier (Heinzen and Hackstadt,
1997). It has a neutral pH and is permeable to ions (Grieshaber
et al., 2002), yet impermeable to compounds larger than 520 Da
(Heinzen and Hackstadt, 1997). In order to effectuate the uptake
of metabolites by means of chlamydial nutrient transporters,
embedded in the pathogens cell wall, the necessary metabolites
need to be present in the inclusion lumen.
Eukaryotic lipids are obtained via vesicular and non-vesicular
pathways (as discussed in great detail later in this review). In
the former process, also soluble nutrients contained inside the
host-derived vesicles could be provided to the bacteria by means
of vesicle fusion with the inclusion membrane. However, the
composition of the solutes which are present in the lumen of
many intracellular vesicles remains unknown and therefore the
ability of such metabolites to fulfill the needs of chlamydiae is
arguable (Haferkamp, 2017). On the other hand, the inclusion
membrane might also contain transport proteins, which mediate
the passage of specific solutes. This hypothesis is supported by
proteomic analyses of the inclusion membrane, revealing the
presence of several host proteins, including membrane proteins
of the ER, the Golgi apparatus and the plasma membrane
(Saka et al., 2011; Aeberhard et al., 2015; Herweg et al., 2015,
2016). In the following, some examples of inclusion membrane
transporters are provided, accompanied with their respective
chlamydial body nutrient transporters.
Biotin is a vitamin which functions as a cofactor for multiple
carboxylase enzymes. Although some Chlamydia species have the
enzymatic repertoire for de novo synthesis (e.g., C. pneumoniae),
others do not and thus depend on biotin hijacking (e.g.,
C. trachomatis) or can do both (e.g., C. psittaci). Uptake of
biotin by the bacteria is mediated by transporter BioY, provided
that biotin is present in the inclusion lumen. In case of cells
infected with C. trachomatis, host SMVT, a biotin transporter,
is redirected from the plasma membrane to the inclusion
membrane. Interestingly, the host cell expression of SMVT gets
upregulated under conditions of increased demand, e.g., due to
biotin uptake by the pathogen (Fisher et al., 2012).
Because the genome of C. trachomatis lacks most biosynthetic
pathways for amino acids (Stephens et al., 1998; Read et al., 2000),
the pathogen hijacks most amino acids from the host as well
(Bader and Morgan, 1958; Mehlitz et al., 2017). Nevertheless, it
appears that C. trachomatis synthesizes a small fraction of alanine,
aspartate and glutamate de novo (Mehlitz et al., 2017). Especially
the use of host-derived molecules in providing chlamydiae with
tryptophan appears to be crucial. Some species require the host-
derived precursor kynurenine for tryptophan synthesis since they
only possess part of the biosynthetic pathway (C. caviae, C. felis,
and C. pecorum) whilst others require host-derived tryptophan
itself because they lack the full biosynthetic pathway (C. abortus,
C. pneumoniae and C. psittaci) (Xie et al., 2002). This dependence
of chlamydiae for tryptophan is used by the hosts immune
response by employing tryptophan starvation, a IFNγ-driven
process, in an attempt to clear chlamydiae. However, tryptophan
starvation can either kill the tryptophan auxotrophic Chlamydia
(Byrne and Beatty, 2012) or alter their gene transcription and
metabolism, thereby transforming them into a persistent state
(Beatty et al., 1993, 1994). Moreover, genital C. trachomatis
serovars kept a relict pathway, utilizing indole for tryptophan
synthesis, a trait the ocular serovars lost. Interestingly, in this case,
the indole is not a product from human host cells but rather from
indole-producing microbiota that can co-exist in the genital tract
in case of bacterial vaginosis (Ziklo et al., 2016). Hence, strain-
specific tropism is also correlated with the ability to hijack indole
from a co-existing microbial community (Fehlner-Gardiner et al.,
2002). Genome analysis showed that C. trachomatis possesses
at least one carrier for tryptophan uptake (Bonner et al., 2014).
The tryptophan is first shuttled from the host cytosol to the
inclusion lumen by means of two components of the human
amino acid uptake system: SLC7A5 and SLC3A2 (Aeberhard
et al., 2015). These components can form a heterodimer through
covalent interactions, which then functions as an amino acid
antiporter that prefers large amino acids (Wagner et al., 2001).
The latter include tryptophan but also phenylalanine, tyrosine
and histidine. Nevertheless, transport of smaller amino acids such
as methionine, valine, or leucine is also possible (Kanai et al.,
1998; Yanagida et al., 2001).
Glycogen is a multi-branched glucose polysaccharide that
represents an important energy storage compound for animals,
humans, and bacteria. C. trachomatis RBs store glycogen in the
inclusion lumen (Gordon and Quan, 1965) and later, during RB-
EB transition, tap from this supply to build up an intra-bacterial
glycogen stock. In the latter scenario, luminal glycogen gets
degraded into glucose-1-phosphate and subsequently converted
to glucose-6-phosphate. Chlamydiae rely on the import of
phosphorylated sugars because they lack a hexokinase, the
enzyme phosphorylating glucose (Gehre et al., 2016). Plausible
glucose-6-phosphate transporter have yet been suggested for
C. trachomatis and C. pneumoniae (Schwöppe et al., 2002).
A minor amount of the glycogen, present in the lumen
of the inclusion, is acquired by translocation in bulk via
vesicular pathways. However, the majority of the glycogen in
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the inclusion lumen is synthesized de novo by means of two
secreted bacterial enzymes: bacterial glycogen synthase GlgA and
branching enzyme GlgB. The required precursor, host-derived
UDP-glucose, enters the inclusion via solute carrier SLC35D2,
embedded in the inclusion membrane (Gehre et al., 2016).
Moreover, Chlamydia is shown to induce host hexokinase II, an
enzyme known to play a critical role in regulating glucose entry
into the cell by catalyzing the first step in glucose metabolism
(Al-Zeer et al., 2017).
The group of Wang et al. (2017) demonstrated that Chlamydia
exploits host-derived transporter proteins glucose transporter
proteins 1 and 3 (GLUT1 and GLUT3) to fulfill its carbon
source requirements by altering their expression, turnover
and localization. Knockdown of these protein, using siRNA,
clearly affected chlamydial development. The upregulation of
GLUT1 and GLUT3 during chlamydial infection was proven
to be dependent on bacterial protein synthesis and Chlamydia-
induced MAPK kinase activation. Furthermore, GLUT1, but
not GLUT3, was proven to be in close proximity to the
inclusion membrane throughout the chlamydial life cycle and
this proximity was dependent on a brefeldin A-sensitive pathway.
Finally, stabilization of GLUT1 through inhibition of host-
dependent ubiquitination by chlamydial deubiquitinase effector
protein CT868 was explained (Wang et al., 2017).
A Npt1 antiporter is present in the chlamydial cell wall
and catalyzes the uptake of host-derived ATP in exchange for
bacterial ADP and phosphate (Tjaden et al., 1999; Trentmann
et al., 2008). This implies that the presence of ATP in the
inclusion lumen is necessary and that ADP and phosphate have
to be eliminated. The latter is mandatory since these molecules
can outcompete ATP in the binding of Npt1. Delivery of ATP
could be completed via vesicle fusion, however, as mentioned
previously, whether or not vesicles provide the inclusion with
solutes remains unknown. Moreover, the need to remove ADP
and phosphate points in the direction of carrier-mediated
nucleotide translocation. Therefore, it is assumed that host
adenine nucleotide transporters from the ER and/ Golgi are
inserted in the inclusion membrane, although possible candidates
remain unknown. However, remarkably, it appears that inclusion
membranes also contain Npt1 (Saka et al., 2011).
Interactions Between Inclusions and
Mitochondria
Mitochondria were found in close association with C. psittaci
and C. caviae inclusions, but this association was not observed
in C. trachomatis and C. pneumoniae-infected cells (Matsumoto
et al., 1991; Vanrompay et al., 1996). The translocase of the
inner membrane–translocase of the outer membrane (TIMTOM)
complex, proven to be involved in the recognition and transport
of host mitochondrial proteins into the mitochondria, is essential
for C. caviae and C. trachomatis inclusion biogenesis and the
production of infectious progeny. Depletion of this complex
disrupts their chlamydial infection (Kokes and Valdivia, 2012;
Gurumurthy et al., 2014). The functional significance of these
associations might be related to the hijacking of energy
metabolites. Although chlamydiae have the capacity to produce
ATP, the genes required are only transcribed starting from
6 h post infection. Therefore, energy needed for the early
differentiation of EBs to RBs might either come from chlamydial
ATP reserves but also from the host (Iliffe-Lee and McClarty,
1999). This hypothesis is supported by the fact that chlamydiae
contain mimic-ATP transporters Npt1 and Npt2 in their EB, RB
and inclusion membranes, as mentioned before (Tjaden et al.,
1999; Saka et al., 2011). However, prevention of apoptosis is
also suggested as a reason to why inclusions associate with
mitochondria. The release of mitochondrial cytochrome c into
the cytoplasm is crucial to induce apoptosis (Yang, 1997).
This being said, one of the observed effects of chlamydial
effectors is the prevention of mitochondrial cytochrome c
release into the host cytoplasm (Fan et al., 1998). Prevention
of host cell apoptosis is of great interest for the obligate
intracellular pathogen for completion of its life cycle. Other
recently discovered chlamydial anti-apoptotic strategies involve
the induced expression and increased stabilization of host anti-
apoptotic proteins such as Mcl-1 (Rajalingam et al., 2008;
Sarkar et al., 2015) and inhibitor of apoptosis proteins IAPs
(Prakash et al., 2009), and the upregulation of specific members
a group of diverse miRNAs, called apoptomirs. These miRNAs
target several pro- as well as anti-apoptotic proteins and thus
influence apoptotic signaling pathways. Chowdhury et al. (2017)
observed that C. trachomatis significantly upregulates miR-30c-
5p, which targets tumor suppressor protein p53. Subsequent
loss of p53 is of interest for chlamydiae since activation of p53
suppresses the pentose phosphate pathway, which is essential
to chlamydial growth (Chowdhury et al., 2017). Moreover,
miR-30c-5p also downregulates the major mitochondrial fission
regulator, Drp1 and therefore obstructs fission of mitochondria,
due to both intrinsic and extrinsic pro-fragmentation stimuli,
and the subsequent degradation of the resulting fragments. This
preservation of the mitochondrial architecture is beneficial for
chlamydiae since the mitochondria represent an essential source
of ATP (Chowdhury et al., 2017).
Interactions Between Inclusions and
Lysosomes
Although chlamydiae modify the inclusion membrane to prevent
fusion with the endolysosomal pathway, lysosomes reside in
close proximity of the inclusion membrane. Therefore, Ouellette
et al. (2011) hypothesized the possibility that Chlamydia hijack
lysosomal amino acids and/or oligopeptides. This hypothesis
was proven by the labeling of chlamydiae that were grown
inside cells which were administered labeled proteins as an
exogenous nutrient source (Ouellette et al., 2011). Moreover,
treatment with Bafilomycin A1 (BafA1), an inhibitor of the
vacuolar H+/ ATPase that blocks lysosomal acidification,
impaired the growth of C. trachomatis and C. pneumoniae, with
more profound effects in the latter. This inhibition of growth
was further proven not to be due to changes in lysosomal
acidification per se, since cathepsin inhibitors also inhibited
growth. Finally, Ouellette et al. (2011) showed that EBs contain
both amino acid and oligopeptide transporters whilst early
after differentiation, RBs predominantly use their oligopeptide
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transporters in order to acquire oligopeptides from lysosomes.
However, later in the infection cycle, C. trachomatis uses its
amino acid transporters to hijack free cytosolic amino acids,
whereas C. pneumoniae continues to depend on lysosome-
derived oligopeptides (Ouellette et al., 2011).
Vesicular and Non-vesicular Pathways
In addition to employing the nutrient transporters that are
embedded in its membrane, the inclusion selectively interacts
with organelles in the peri-Golgi niche in order to sequester
essential factors for chlamydial development. Despite the fact
that chlamydiae are capable in producing the common bacterial
lipids, it is imperative for their development and survival
that eukaryotic lipids are also present in their membranes.
Sphingolipids (Hackstadt et al., 1996), cholesterol (Carabeo
et al., 2003), and glycerophospholipids (Wylie et al., 1997)
are essential for several processes including but not limited to
chlamydial replication, growth, reactivation from persistence and
RB to EB re-differentiation. Since chlamydiae lack the required
biosynthetic enzymes, sophisticated interaction with various host
pathways are exerted to acquire those eukaryotic lipids, involving
vesicular and non-vesicular pathways (Figure 5). However, Gilk
et al. (2013) observed that cholesterol precursors may be sufficient
for enabling C. trachomatis infection since C. trachomatis growth
and inclusion formation were unaffected in cholesterol-free
mouse embryonic fibroblasts (Gilk et al., 2013).
Vesicular Pathways
Golgi apparatus
The Golgi apparatus fragments into mini-stacks during the
mid-cycle stages of C. trachomatis infection. These fragments
surround the inclusion in order to increase the efficiency in
delivery of eukaryotic lipids. Furthermore, artificial enhancement
of mini-stack formation by depletion of Golgin-84 is proven
to increase infectious progeny production (Heuer et al., 2009).
However, fragmentation is not imperative to the growth of
C. trachomatis and to lipid uptake (Gurumurthy et al., 2014).
Deubiquitinase activity of the chlamydial effector ChlaDUB1
was recently proven to be linked to the fragmentation of the
host Golgi apparatus (Pruneda et al., 2018). Around 12 h post-
infection, a “cage” of post-translationally modified microtubules
surrounds the inclusion and controls the positioning of Golgi
complex mini-stacks around it (Al-Zeer et al., 2014). The post-
translational modifications influence microtubule structure and
depolymerization rates and particularly include acetylated and
detyrosinated tubulin (Peris et al., 2009). Wesolowski et al.
(2017) showed that the Inc CT813 controls posttranslational
modifications and the positioning of the mini-stacks around
the inclusion through the recruitment and activation of host
Arf GTPases, Arf1 and Arf4. Interestingly, since Arf GTPases
get activated by Arf GEFs through nucleotide exchange but
CT813 does not display GEF activity, it is believed that CT813
recruits or cellular GEFs or another unidentified compound
that allows CT813 to function as a GEF. The latter hypothesis
is the most plausible one since CT813 behaves as a GEF by
interacting with Arf-GDP as well as Arf-GTP and, moreover,
competes with cellular GEFs in vitro (Mueller and Goody, 2016).
Moreover, Al-Zeer et al. (2014) suggest that RhoA and ROCK
(Rho-associated protein kinase) activity are essential for the
recruitment and/or assembly of stable microtubules at the
inclusion membrane. Finally, data from the group of Dumoux
et al. (2015) mechanistically complemented and extended this
model, as they identified C. trachomatis effector IPAM as
an initiator of microtubule organization around the inclusion
through its recruitment of CEP170. As mentioned previously, in
addition to microtubule cages, the chlamydial inclusion is also
surrounded by a network of actin, which ensures integrity of the
inclusion (Kumar and Valdivia, 2008). Interestingly, since CT813
is proven to also be involved in the formation of these actin
scaffolds (Kokes et al., 2015), CT813 is suggested to be a master
cytoskeletal regulator (Wesolowski et al., 2017).
Sphingomyelin and cholesterol are attained via interception
of exocytic vesicles from these fragmented Golgi-mini-stacks,
destined for the plasma membrane (Hackstadt et al., 1996;
Carabeo et al., 2003) and via multivesicular bodies (see
‘Translocation into the inclusion’) (Beatty, 2006, 2008; Kesley
Robertson et al., 2009). In the former acquisitioning strategy,
host proteins such as Rab GTPases (specifically, Rab6, Rab11
and Rab14 in case of C. trachomatis) (Lipinski et al., 2009;
Capmany et al., 2011) and Rab11FIP2 (Leiva et al., 2013), SNARE
proteins (Kabeiseman et al., 2013), Arf GTPases (Moorhead et al.,
2010; Reiling et al., 2013), the Arf guanine nucleotide exchange
factor GBF1 (Elwell et al., 2011), dynamin (Gurumurthy et al.,
2014) and FYN kinase (Mital et al., 2010; Mital and Hackstadt,
2011a,b) are involved.
Rab GTPases. Several endosome and Golgi-related Rab GTPases,
which are master controllers of intracellular trafficking,
membrane fusion and organelle identity (Seabra and Wasmeier,
2004; Hutagalung and Novick, 2011), associate with the
inclusion membrane. Rab proteins were observed in association
with the inclusion membrane in both a species-dependent
and species-independent manner, depending on the protein.
For example, Rab1, 4, and 11 are recruited to the inclusion
membranes of C. trachomatis, C. muridarum and C. pneumoniae.
In contrast, Rab6 is recruited to the inclusion membranes of
C. trachomatis but not those of C. pneumoniae or C. muridarum,
while the opposite is true for Rab10 (Rzomp et al., 2003;
Brumell and Scidmore, 2007).
Rab GTPases function in various pathways and the
recruitment of different Rabs is suggested to promote selective
interaction and/or fusion with several host vesicles containing
essential nutrients (Bastidas et al., 2013). Chlamydiae hijack
Golgi-associated Rabs (such as Rab6, 11 and 14) to capture
exocytic vesicles enriched in endogenously synthesized host
lipids (Rzomp et al., 2003). Rab6 and 11 mediate fragmentation
of the Golgi into mini-stacks (Heuer et al., 2009; Lipinski
et al., 2009) while Rab14 mediates delivery of Golgi-derived
sphingomyelin to the inclusion (Capmany and Damiani, 2010;
Damiani et al., 2014). On the other hand, Rab GTPases may
also be involved in the acquisition of nutrients other than
those originated in the Golgi apparatus: Rab4 and 11 mediate
interactions with the transferrin slow-recycling pathway in order
to acquire iron. Although Rab4 silencing failed to reveal any effect
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FIGURE 5 | Schematic representation of the vesicular and non-vesicular pathways, employed by C. trachomatis. The inclusion selectively interacts with organelles in
the peri-Golgi region by means of vesicular and non-vesicular pathways in order to sequester eukaryotic lipids for chlamydial development and survival. These lipids
include sphingolipids, cholesterol and glycerophospholipids. The hijacking of lipids derived from the Golgi apparatus is facilitated by the positioning of mini-stacks
around the inclusion. Sphingomyelin and cholesterol are attained via interception of exocytic vesicles, fragmented from these mini-stacks. Capturing of vesicles is
done by hijacking Golgi-associated Rabs (such as Rab6, 11 and 14), which promote selective interaction and/or fusion between several host vesicles. Rab4 and 11
also mediate interactions with the transferrin slow-recycling pathway in order to acquire iron. Recruitment of these Rabs is done by chlamydial Incs, e.g., CT229
recruits Rab4. Rab11 on his turn recruits Rab11FIP2 and together these recruit Rab14. In addition to trafficking, Rabs also promote vesicle fusion by recruiting lipid
kinases such as inositol polyphosphate 5-phosphatase OCRL1, a Golgi-localized enzyme and PI4KIIα. Both produce the Golgi-specific lipid PI4P and enrichment of
the latter is considered a strategy to disguise the inclusion as a specialized compartment of the Golgi apparatus. Furthermore, chlamydiae interact with trans-Golgi
STX6 and STX10, VAMP4 and GS15. These also regulate the acquisition of nutrients from the Golgi exocytotic pathway. Moreover, GBF1, a regulator of
Arf1-dependent vesicular trafficking within the early secretory pathway is employed. Finally, growth of C. trachomatis is depending on interactions with DYN1, a large
GTPase that induces scission of vesicles from, among others, the Golgi apparatus. Whether or not FYN kinase regulates vesicle-mediated trafficking is currently
unknown. However, it is hypothesized that FYN mediates linkage of the inclusion to the microtubule network, thereby intersecting sphingomyelin-containing vesicles
that traffic along the microtubules. LDs, peroxisomes and MVBs also represent useful sources for eukaryotic lipids and get translocated fully into the inclusion. LDs
are ER-derived storage organelles for neutral lipids or long chain fatty acids. Lda3 gets translocated to the host cytosol after which it links cytoplasmic LDs to the
inclusion membrane. Furthermore, it was suggested that IncA might mark the entry sites for LDs at the inclusion membrane. The mechanisms of peroxisome and
MVB uptake are still unclear, although Rab39 was shown to participate in the delivery of MVBs to the inclusion. ER derived sphingomyelin on the other hand is
acquired via non-vesicular pathways. The existence of ER-inclusion MCSs was shown in which CERT, ER-resident protein VAPB, SMS2 and ER calcium sensor
STIM1 are enriched. CERT is proven to be recruited to these MCSs via direct interaction with IncD, which in turn leads to the binding of CERT with VAPB. It is
believed that CERT and VAPB participate to the non-vesicular trafficking of ceramide, the precursor of sphingomyelin, from the ER to the inclusion, after which
ceramide is further converted into sphingomyelin by SMS2. The role of STIM1 remains unanswered. Besides CERT also IncV is able to interact with VAPs, possibly
assisting in ER-inclusion tethering. Another non-vesicular pathway involves the co-opting of the host cell lipid transport system involved in the formation of HDLs.
HDL is formed when cholesterol and phospholipids are transported to extracellular ApoA-1 by the lipid binding proteins ABCA1 and ABCG1 and CLA1. ABCA1,
CLA1 and ApoA-1 are shown to be localized at the inclusion membrane. Lastly, PI and PC are acquired via another non-vesicular pathway, mediated by ERK
and cPLA2.
on the pathogen, simultaneous depletion of Rab4 and Rab11
impaired chlamydial growth (Ouellette and Carabeo, 2010).
Chlamydial Incs probably recruit host-derived Rabs through
species-specific interactions (Rzomp et al., 2003). For example,
the C. pneumoniae Inc Cpn0585 interacts with Rab1, 10 and
11 (Cortes et al., 2007). Rab11 on its turn recruits the Rab11
effector, Rab11 family interacting protein 2 (Rab11FIP2) and
together they promote the recruitment of Rab14 (Leiva et al.,
2013). Since it is unclear for C. trachomatis which Inc interacts
with Rab11 and since their genome does not encode a protein that
is homologous to Cpn0585, binding partners could possibly be
detected by performing sequence comparison studies, restricted
to the functional regions of Cpn0585 (Cortes et al., 2007).
C. trachomatis Inc CT229 recruits among others Rab4 (Rzomp
et al., 2006). Moreover, the importance of CT229 in forming and
maintaining the intracellular niche of C. trachomatis is proven
by the fact that absence triggers premature inclusion lysis and
host cell death (Weber et al., 2017). Moreover, recently, the group
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of Faris et al. (2019) demonstrated that CT229 recruits multiple
Rab GTPases and their cognate effectors to the inclusion and
that CT229 redirects and intercepts host clathrin-coated vesicles
from the recycling pathway and thereby regulates the trafficking
of transferrin and the mannose-6-phosphate receptor.
Incs are a family of T3S effector proteins which are
expressed at several time point during the developmental cycle
(Nicholson et al., 2003) but primarily early in the infection,
when they are important in the escape of the inclusion from
the endolysosomal pathway, and at mid-cycle, when they are
essential in the acquisition of host-derived nutrients (Moore
and Ouellette, 2014). Incs are identified by one or more
N-terminal bilobed hydrophobic domains, composed of two
closely spaced membrane-spanning regions that are separated
by a short hairpin loop (Bannantine et al., 2000). Furthermore,
their amino terminus and/or carboxyl terminus is predicted
to extend into the cytoplasm of the host cell (Rockey et al.,
2002; Hackstadt, 2012). Finally, the N-terminal type 3 secretion
signal that allows the secretion and subsequent insertion of
the proteins into the inclusion membrane is also an identifier
(Bauler and Hackstadt, 2014; Moore and Ouellette, 2014). During
a bioinformatics study by Lutter et al. (2012) the following
numbers of Incs were identified: 55 in C. trachomatis, 68 in
C. felis, 92 in C. pneumoniae, 79 in C. caviae and 54 in
C. muridarum. Furthermore, Inc homologues were compared
across these five species and a core set of 23 Incs was identified
as shared among all, possibly representing proteins involved in
conserved interactions between chlamydiae and the host. On
the other hand, the diversification of Incs between these species
suggests the involvement of certain Incs in unique pathogenic
pathways. Moreover, genomic expansion of Incs was identified
in C. pneumoniae, C. caviae and C. felis but not C. trachomatis
or C. muridarum. Finally, Lutter et al. (2012) pointed out
that, besides the previously mentioned Pmps and Tarp, also
some C. trachomatis Incs clustered the different biovars, thus
suggesting that these proteins may also contribute to tissue
tropism. Furthermore, also the group of Almeida et al. (2012)
pointed out that subtle variations in the amino acids of a subset
of C. trachomatis Incs and in their expression might contribute
to the invasive character of C. trachomatis LGV strains. The 50
genes coding for Incs represent approximately 6% of the coding
capacity of C. trachomatis (Stephens et al., 1998). Given the highly
reduced genome of chlamydiae, Incs thus serve an important
function (Moore and Ouellette, 2014).
In addition to trafficking, Rabs also promote vesicle
fusion by recruiting lipid kinases such as the inositol
polyphosphate 5- phosphatase OCRL1 (also known as Lowe
oculocerebrorenal syndrome protein), a Golgi-localized enzyme,
and phosphatidylinositol-4-kinase type IIα (PI4KIIα). Both
produce the Golgi-specific lipid phosphatidylinositol-4-
phosphate (PI4P). The enrichment of PI4P is considered a
strategy to disguise the inclusion as a specialized compartment of
the Golgi apparatus (Moorhead et al., 2010).
SNARE proteins. Vesicular pathways might also be regulated
by the recruitment of host soluble N-ethyl-maleimide-sensitive
factor attachment receptor (SNARE) proteins, which are
key components of the intracellular fusion machinery
(Südhof and Rothman, 2009). Chlamydiae interact, among
others, with trans-Golgi SNARE proteins syntaxin 6 (STX6)
(Moore et al., 2011) and STX10 (Lucas et al., 2015), vesicle-
associated membrane protein 4 (VAMP4) (Kabeiseman et al.,
2013) and GS15 (also known as BET1L) (Pokrovskaya et al.,
2012). These regulate the acquisition of nutrients from the
Golgi exocytic pathway. The group of Kabeiseman et al. (2013)
observed that knockdown of VAMP4 prevented localization
of STX6 to the chlamydial inclusion, 1 year later, proved that
STX6 is trafficked to the chlamydial inclusion by means of its
YGRL signal sequence, after which it interacts with VAMP4 and
remains on the inclusion membrane (Kabeiseman et al., 2014).
Remarkably, chlamydiae also use SNARE motifs to inhibit
vesicle fusion through molecular mimicry by Incs. At least
three Incs contain SNARE-like motifs, enabling them to act
like SNARE proteins and limit fusion with compartments that
contain VAMP3, VAMP7, or VAMP8, all three SNAREs involved
in endosomal trafficking (Delevoye et al., 2008; Kokes and
Valdivia, 2012; Ronzone and Paumet, 2013). These Ins include
IncA (also known as CT119), InaC (also known as CT813) and
an Inc, acting on microtubules (IPAM or CT223) (Delevoye
et al., 2008). IncA is exposed on the cytosolic face of the
C. trachomatis inclusion membrane (Hackstadt et al., 1999) and
displays two coiled-coil domains, which show high homology
with SNARE proteins. IncA inhibits host endocytic SNARE-
mediated membrane fusion for target SNAREs, positioned on
the same membrane as IncA (Paumet et al., 2009; Ronzone and
Paumet, 2013). However, IncA is also involved in the induction
of inclusion homotypic fusion (Hackstadt et al., 1999; Suchland
et al., 2000). In host cells which are multiply infected with
C. trachomatis, the inclusions fuse to form a single large vacuole
(Blyth and Taverne, 1972; Ridderhof and Barnes, 1989). Since
the absence of IncA correlates with the formation of multilobed
non-fusogenic inclusion bodies, homotypic vesicle fusion of
inclusions relies on IncA (Suchland et al., 2000; Pannekoek et al.,
2005). Moreover, IncA-negative strains were studied by the group
of Geisler et al. (2001) who showed that non-fusogenic clinical
isolates induced less severe clinical signs of infection with low
Chlamydia recovery. The mechanism by which IncA regulates the
delicate balance between blocking lysosomal membrane fusion
and promoting homotypic inclusion fusion remains elusive.
However, Ronzone and Paumet proved that although both coiled-
coil domains of IncA are each on their own capable to inhibit
SNARE-mediated fusion, cooperation between these two coiled-
coil domains is essential in mediating IncA multimerization and
homotypic membrane fusion.
Arf GTPases and GBF1. The hijacking of host sphingomyelin
from Golgi is a Brefeldin A (BFA)-sensitive vesicular trafficking
pathway (Hackstadt et al., 1996; Elwell et al., 2011). Elwell et al.
(2011) showed that C. trachomatis selectively opts only one of the
three known BFA targets: GBF1, a regulator of Arf1-dependent
vesicular trafficking within the early secretory pathway. The
Arf1/GBF1-dependent pathway of sphingomyelin acquisition is
proven to be crucial for the growth of the inclusion membrane,
yet not necessary for bacterial amplification (Elwell et al., 2011).
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Dynamin. Dynamin is a large GTPase that induces scission of
vesicles from, among others, the Golgi apparatus and that is
necessary for the formation of both clathrin-coated and non-
clathrin-coated vesicles from the trans-Golgi network. It appears
that dynamin is required for the growth of C. trachomatis
because it is essential for homotypic fusion of the C. trachomatis
inclusions. Moreover, suppressing of dynamin activity leads to
the disruption of lipid trafficking into C. trachomatis inclusions
and dynamin-mediated lipid acquisition is proven to be unrelated
to Golgi-fragmentation. Finally, dynamin activity is shown to
be necessary for normal re-differentiation from RBs to EBs
(Gurumurthy et al., 2014).
FYN kinase. Mital and Hackstadt identified host protein FYN
kinase, part of the SFKs, as a regulator of sphingomyelin
acquisition in C. trachomatis since depletion of FYN kinase
decreased sphingolipid retention by both the inclusion and
EBs. However, since infectious progeny was still produced,
despite this depletion, the FYN kinase pathway was assumed
to be redundant to other lipid trafficking pathways (Mital and
Hackstadt, 2011b). Moreover, as mentioned earlier, Mital et al.
(2010) have shown that for C. trachomatis, four Incs (IncB,
Inc101, Inc222, and Inc850) co-localized with the active FYN and
other active Src kinases in discrete cholesterol-rich microdomains
at the point of centrosome–inclusion contact, making it likely
that these Incs participate in transport of the inclusion along
microtubules. Whether FYN kinase regulates vesicle-mediated
trafficking from the Golgi apparatus and/or MBVs to the
chlamydial inclusions and whether Fyn plays a role in cholesterol
acquisition is currently unknown. However, it is hypothesized
that FYN mediates linkage of the inclusion to the microtubule
network, thereby intersecting sphingomyelin-containing vesicles
that traffic along the microtubules (Mital and Hackstadt, 2011a).
CteG. Very recently, the group of Pais et al. (2019) identified
CT105 as a T3S effector of C. trachomatis. CT105 was shown
to localize to the Golgi-apparatus and the plasma membrane
of infected host cells. Moreover, they showed that CT105 can
modulate eukaryotic vesicular trafficking. Because CT105 is the
first Chlamydia effector proven to associate with the Golgi
complex, they named the protein CteG (for C. trachomatis
effector associated with the Golgi). However, no information
is gathered yet on the function and subcellular targeting
mechanisms of CteG as well as its diversity and specificity within
C. trachomatis and among Chlamydia species (Pais et al., 2019).
Translocations into the inclusion
Lipid droplets. Lipid droplets (LD) are ER-derived storage
organelles for neutral lipids or long chain fatty acids (Martin and
Parton, 2006; Cocchiaro et al., 2008). Three C. trachomatis LD-
associated proteins were identified: Lda1, Lda2, and Lda3 (Kumar
et al., 2006). The roles of Lda1 and Lda2 are unknown to date.
Contrarily, ectopical expression of Lda3 shows that it has tropism
for both LDs and the inclusion membrane, indicating its potential
to act as a molecular bridge between them (Cocchiaro et al.,
2008). Cocchiaro et al. (2008) proposed a model in which secreted
Lda3 binds to LDs in the vicinity of the inclusion, where after
the Lda3-tagged LDs then dock with the inclusion membrane by
binding to a hypothetical chlamydial protein (IncX). Next, the
inclusion membrane would invaginate to deliver an intact LD
into the inclusion lumen, where it intimately associates with RBs.
Furthermore, since IncA cofractionated with LDs, accumulated
in the inclusion lumen and partially colocalized with intraluminal
LDs, it was suggested that IncA might mark entry sites for LDs at
the inclusion membrane. Moreover, Lda3 might also participate
in the hijacking of host LDs by promoting the removal of the LD
protective coat protein, adipocyte differentiation related protein
(ADRP) (Cocchiaro et al., 2008). Moreover, Saka et al. (2015)
noted that IncG (CTL00373/CT118), Cap1 (CTL0791/CT529),
CTL0882 (CT618) also associated with LDs when ectopically
expressed in host cells. They thus speculated that the expression
of these Incs may again represent a bacterial strategy to promote
the previously reported close association of these organelles
with inclusion membranes (Saka et al., 2015). Furthermore, LD-
associated proteins might also influence chlamydiae. The human
acyl-CoA carrier, acyl-CoA-binding domain-containing protein
6 (ACBD6), for example affects the bacterial acyltransferase
activity of CT775, thus the formation of phophatidylcholine in
C. trachomatis (Soupene et al., 2015).
Excess cholesterol is esterified by acyl CoA transferase (ACAT)
prior to packaging in LDs. Expression of ACAT1 is increased in
HP-1 cells infected with C. pneumoniae, resulting in a higher
level of esterified cholesterol (Liu et al., 2010). Moreover, a
decreased in cholesterol efflux, discussed later in section ‘HDL
biogenesis,’ results in cholesterol accumulation within the host
cell (Samanta et al., 2017).
The observation that the LDs do not accumulate in the
inclusion lumen led to the suggestion that they are consumed,
either for energy generation and/or as a source of fatty acids for
lipid biosynthesis (Cocchiaro et al., 2008). However, the group
of Sharma et al. (2018) states that it is not the LDs per se, but
the availability of fatty acids in the host cells that contribute to
the growth and development of C. trachomatis. It is believed that
C. trachomatis CT149 might liberate cholesterol from LDs for use
of bacteria since LDs store cholesterol esters. CT149 was localized
inside the inclusion lumen by means of antibodies (Peters et al.,
2012; Samanta et al., 2017). It is a putative carboxylic esterase
containing a cholesterol recognition consensus sequence and two
GXSXG cholesterol esterase motifs. Cholesterol esterase activity
of recombinant CT149 was proven in vitro. Moreover, cholesterol
ester levels decreased and free cholesterol levels increased when
ectopically expressing CT149 in HeLa cells (Peters et al., 2012;
Samanta et al., 2017).
Peroxisomes. Three-dimensional fluorescence microscopy
revealed that peroxisomes are translocated into the chlamydial
inclusion as well, where they are located adjacent to the bacteria.
The mechanism of peroxisome uptake, however, is still unclear.
Boncompain et al. (2014) have shown that peroxisomes are not
essential for bacterial development in vivo since chlamydiae
are able to multiply and form infectious progeny in host cells,
deficient for peroxisome biogenesis.
Multivesicular bodies. Multivesicular bodies (MVBs) are
heterogeneous late endocytic organelles essential for the sorting
and processing of proteins and lipids that are destined for
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lysosomal degradation, recycling to the Golgi, or plasma
membrane exocytosis (Denzer et al., 2000; Piper and Luzio, 2001;
Woodman and Futter, 2008). Chlamydiae use the MVBs as an
additional lipid (sphingolipids, phospholipids, and cholesterol)
source by translocating the MVBs into the inclusion (Beatty,
2006; Gambarte Tudela et al., 2015). Different MVB markers,
such as CD63 and lysobisphosphatidic acid (LBPA), localize to
the C. trachomatis inclusion lumen (Beatty, 2006). MVBs migrate
along microtubules toward the inclusion and Rab39, which labels
a subset of late endosomal vesicles, mainly MVBs, participates
in the delivery of the MVBs to the inclusion (Gambarte Tudela
et al., 2015). However, the chlamydial effectors involved in
the transport of MVB into the inclusion lumen are unknown
(Gambarte Tudela et al., 2015; Dumoux and Hayward, 2016).
Non-vesicular Pathway
One chlamydial non-vesicular mechanism is the use of lipid
transporters such as, among others, host ceramide endoplasmic
reticulum transport protein (CERT) (Derré et al., 2011; Elwell
et al., 2011). Sphingomyelin synthase 2 (SMS2), which is recruited
to the inclusion, probably converts the transported ceramide
into sphingomyelin (Elwell et al., 2011). Other chlamydial
non-vesicular mechanisms include the use of members of the
high-density lipoprotein (HDL) biogenesis machinery and the
activation of phospholipase A2 and ERK in order to deliver
respectively host phosphatidylcholine (Cox et al., 2012) and
glycerophospholipids (Su et al., 2004). All aforementioned non-
vesicular mechanisms will be discussed in more detail in the
following sections.
CERT/VAPB/IncD and SMS2
Host-myelin is essential for progeny production and inclusion
biogenesis (Van Ooij et al., 2000; Kesley Robertson et al., 2009).
Earlier, the use of vesicular pathways to transport sphingomyelin-
containing vesicles from the Golgi apparatus to the inclusion
was explained. However, BFA-mediated inhibition of vesicular
transport shows no effect on the production of infectious
progeny (Hackstadt et al., 1996; Hatch and Mcclarty, 1998). This
observation suggests the existence of non-vesicular pathways,
fulfilling the pathogens need for host-myelin.
Chlamydia trachomatis inclusions are shown to be covered
with multiple patches of endoplasmic reticulum (ER) at a distance
of 10–20 nm from the inclusion membrane (Giles and Wyrick,
2008; Derré et al., 2011; Dumoux et al., 2012). Since zones
of close apposition (10-50 nm) between two organelles are
usually defined as Membrane Contact Sites (MCSs) (Levine and
Loewen, 2006), the points of contact between the ER and the
C. trachomatis inclusion membrane were named ER-Inclusion
MCSs (Derré et al., 2011). Several proteins, specifically enriched
at ER-inclusion MCSs of C. trachomatis have been identified.
The ceramide transfer protein CERT is a functional
component of ER-Golgi MCSs, involved in the non-vesicular
transfer of ceramide from the ER to the Golgi (Hanada et al.,
2009). CERT is proven to be recruited to the ER-inclusion MCS
for C. trachomatis infections via direct binding of IncD to the
CERT Pleckstrin homology (PH) domain (Derré et al., 2011;
Agaisse and Derré, 2014). Amino acid substitution in IncD of
ocular and LGV strains of C. trachomatis are believed to be
involved in the enabling of tissue tropism (Borges et al., 2012;
Sugiki et al., 2012). Furthermore, Derré et al. (2011) showed
that the binding of IncD to CERT mediates the CERT FFAT
motif-dependent recruitment of the ER-resident protein VAPB.
However, it remains unclear whether the IncD-CERT-VAPB
interaction is sufficient to translocate the ER to the inclusion
surface (Derré et al., 2011). Besides CERT, the ER calcium
sensor STIM1 is highly enriched at the ER-inclusion MCSs
and both proteins colocalize at all stages of the developmental
cycle (Agaisse and Derre, 2015). However, while CERT or
VAPB depletion affects C. trachomatis growth (Derré et al.,
2011; Elwell et al., 2011), STIM1 depletion does not, leaving the
functional role of the latter unexplained (Agaisse and Derre,
2015). Moreover, Stanhope et al. (2017) recently showed that
also IncV is able to interact with VAPs, possibly assisting in
ER-inclusion tethering.
In the light of the proposed non-vesicular pathway to supply
the inclusion with host-myelin, the recruitment of CERT at
the ER-Inclusion MCSs represents a plausible strategy to traffic
ceramide from the ER to the inclusion. However, in this
scenario the hijacked ceramide still needs to be converted into
sphingomyelin. Indeed, sphingomyelin synthase 2 (SMS2) also
gets recruited to the inclusion membrane (Derré et al., 2011;
Elwell et al., 2011). Moreover, Elwell et al. (2011) hypothesized
that sphingomyelin, acquired by non-vesicular transport, is
essential for C. trachomatis amplification whilst sphingomyelin
acquired by vesicular transport is crucial for inclusion membrane
expansion and stability (Elwell et al., 2011).
The involvement of CERT in sphingomyelin uptake has also
been studied for the zoonotic pathogen C. psittaci, although
much less extensively compared to C. trachomatis. C. psittaci
also recruits CERT to its inclusion, however, it can also exploit
sphingomyelin pathways independent of CERT. Nevertheless,
chemical inhibition and CRISPR/Cas9-mediated knockout of
CERT affected several stages of the infection including inclusion
growth and infectious progeny formation, thus proving that
CERT is imperative to C. psittaci (Koch-Edelmann et al., 2017).
HDL biogenesis
The high-density lipoprotein (HDL) biogenesis machinery is
involved in cholesterol and phospholipid efflux. In this process,
the lipid binding proteins ATP-binding cassette transporters A1
and G1 (ABCA1, ABCG1), and CLA1 transport the cholesterol
and phospholipids toward extracellular ApoA-1 in order to form
HDL (Samanta et al., 2017). Interestingly, during chlamydial
infection, ABCA1, CLA1, and ApoA-1 localize to the inclusion
membrane and both CLA1 and ApoA-1 are found in discrete foci
within the inclusion lumen (Cox et al., 2012). Furthermore, the
in the inclusion accumulated ApoA-1 co-localized with pools of
phosphatidylcholine. Cox et al. (2012) demonstrated that siRNA
knockdown of ABCA1 in HeLa cells prevented the growth of
C. trachomatis and that pharmaceutical inhibitors of ABCA1
and CLA1 transporter activity also inhibited the recruitment of
phospholipids to the inclusion, preventing chlamydial growth.
These results thus suggested that C. trachomatis exploits the host
cell lipid transport system involved in the formation of HDL
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to acquire lipids that are necessary for growth, although the
mechanism is not clear (Cox et al., 2012). On the other hand,
C. pneumoniae downregulates ABCA1 on a translational and a
post-translational level (by means of microRNA miR-33), thus
targeting cholesterol and phospholipid efflux as a mechanism to
further increase intracellular levels (Korhonen et al., 2013; Sun
et al., 2014; Zhao et al., 2014).
Phospholipase A2 and ERK
Phosphatidylinositol (PI) and phosphatidylcholine (PC), two
eukaryotic glycerophospholipids which are present in purified
EBs, are also acquired from the host cell through a non-
vesicular transport pathway, mediated by ERK and the cytosolic
phospholipase A2 (cPLA2). It is believed that chlamydiae
actively manipulate the host ERK-cPLA2 signaling pathway
since the activation of ERK as well as cPLA2 is reliant on
chlamydial amplification and limited to chlamydia-infected
cells (Su et al., 2004). Chlamydiae modify the sequestered
glycerophospholipids by replacing the non-branched chain fatty
acids by Chlamydia-derived branched chain fatty-acids, which
is in contrast to cholesterol and sphingomyelin that do not get
modified (Wylie et al., 1997).
MOLECULAR GENETIC TOOLS TO
STUDY INFECTION BIOLOGY
The function of many chlamydial proteins, crucial for chlamydiae
on their way from outside to inside the host cell, remains
to be discovered. Studying the role of chlamydial proteins in
pathogenesis and virulence has long been challenging because
of difficulties related to the manipulation of chlamydial genes
(Keb et al., 2018). The transformation of the obligate intracellular
chlamydiae with exogenous DNA is a troublesome process
because host cell and bacterial membranes represent barriers
to reagents. Therefore, Chlamydia genetics will likely never
reach the tractability level of free-living bacteria (Rahnama
and Fields, 2018). In addition, extracellular EBs are not
transformation competent, adding a further level of complication
(Beare et al., 2011; Rahnama and Fields, 2018). Moreover,
because of the considerable reduction of chlamydial genomes
in time, interference of functions by using homologues genes
from other organisms is often impossible (Brothwell et al.,
2016). Nevertheless, recent developments in molecular tools
for the genetic manipulation of chlamydiae are overcoming
the hurdles that used to impede research on the chlamydial
developmental cycle. In what follows, the major advances in
genetic engineering techniques in order to study Chlamydia
infection biology are discussed.
Transformation Through Electroporation
Besides their highly reduced yet conserved genome of ca.
1 Mb, most C. trachomatis isolates carry a cryptic plasmid
of 7.5 kb, encoding eight genes (Stephens et al., 1998;
Seth-Smith et al., 2009). However, despite the ability of
using this plasmid as a vector, genetic manipulation of
chlamydiae has long been challenging (Clarke, 2010). The
first successful artificial transformation of chlamydiae with
recombinant plasmids took place in the year 1994 when
electroporation was proven to be able to introduce DNA into
the EBs of C. trachomatis. The source of DNA for these
experiments was a plasmid called pPBW100, which was a
chimera between the cryptic plasmid of C. trachomatis and
the Escherichia coli plasmid pBGS9. To select directly for
C. trachomatis carrying pPBW100, an in-frame gene fusion
between the chlamydial promoter P7248 and a promoterless
chloramphenicol-resistance cassette was incorporated into the
plasmid. After treatment with chloramphenicol of cultured cells,
infected with the electroporated EBs, pPBW100 was detected
inside the inclusions. Moreover, expression of the resistance
cassette was developmentally regulated and occurred during the
early stages of RB development. However, the expression of the
cassette was mainly transient (Tam et al., 1994). Years later, Binet
and Maurelli (2009) tried to transform C. psittaci EBs in an
attempt to construct variants by homologous recombination. The
single rRNA operon was targeted with a synthetic 16S rRNA
allele, harboring nucleotide substitutions that, among other,
impart resistance to kasugamycin (Ksm) and spectinomycin
(Spc). They succeeded in their aim since double resistance and
replacement of the 16S rRNA gene were observed (Binet and
Maurelli, 2009). The proof-of-concept that was achieved by all
of the before mentioned research demonstrated the potential
to artificially transform chlamydiae and turned out to be the
cornerstone for later developed techniques.
The Discovery Lateral Gene Transfer and
Its Use in Molecular Genetic Tools
The discovery of lateral gene transfer (LGT) via natural
transformation, occurring in chlamydiae opened up new
perspectives for the development of molecular genetic tools
(DeMars et al., 2007; Gomes et al., 2007; DeMars and
Weinfurter, 2008; Jeffrey et al., 2010). Intracellular intra-
and interspecies LGT was shown to be possible, provided
that the involved bacteria cohabitated in a single inclusion
(Jeffrey et al., 2013). New techniques were introduced, using
LGT for passing mutations from one strain to another,
thus enabling genotype–phenotype association studies. Nguyen
and Valdivia for example chemically mutated Chlamydia and
then mapped the underlying genetic lesions by using whole-
genome sequencing (WGS) as well as LGT within infected
cells. More specifically, the alkylating agent ethyl methyl
sulfonate (EMS) was used to mutate Rifampin resistant (RifR)
C. trachomatis RBs after which the resulting progeny was
grown in cell cultures until visible plaques were formed.
Common genetic lesions of mutants, sharing the same plaque
morphotype, were detected through WGS. Next, genotype-
phenotype linkage was studied by coinfecting cell cultures with
the RifR mutants and wild-type SpcR strains and subsequently
selecting recombinant LGT-derived RifR SpcR strains in the
presence of rifampin and spectinomycin. Finally, recombinant
progeny displaying the desired morphotype was analyzed using
targeted DNA sequencing in order to detect segregated individual
mutations that were present in the parental mutant strain
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(Nguyen and Valdivia, 2012). An analogous technique was used
by Brothwell et al. (2016) who screened a library of 4,184 EMS-
mutagenized C. trachomatis isolates for temperature-sensitive
(TS) mutants. These mutants only displayed normal development
at physiological temperature (37◦C). Direct genotype-phenotype
linkage was impossible because all but one of the TS mutants
contained multiple mutations. Therefore, TS mutants were
coinfected and recombinant progeny, growing at the non-
permissive temperature of 40◦C, was selected for. Subsequent
targeted sequencing revealed that the progeny contained all of
the mutations present in one TS parent, with the exception of one
allele (GltXQ487∗) (Brothwell et al., 2016).
Stable Transformation Using a Chimeric
Plasmid, Based on the Chlamydial
Cryptic Plasmid
Wang et al. (2011) developed the first plasmid-based stable
transformation technique for C. trachomatis, based on penicillin
selection. Importantly, the technique relied on a calcium chloride
(CaCl2) treatment of the EBs, rendering them competent (Wang
et al., 2011). The group designed a penicillin-resistance gene-
containing shuttle vector, based on the chlamydial plasmid
and the E. coli plasmid pBR325 and able to replicate in both
species. Furthermore, they demonstrated the effectiveness and
reproducibility of the technique by engineering a penicillin-
resistant strain of C. trachomatis, expressing GFP (Wang et al.,
2011). Results from Wang et al. (2011) presented a turning point
in the field of chlamydial genetics, inspiring researchers to start
analyzing the importance of the chlamydial plasmid genes in
infection biology as well as to use this plasmid in the design
of innovative expression vector platforms (Agaisse and Derré,
2013; Ding et al., 2013; Gong et al., 2013; Johnson and Fisher,
2013; Song et al., 2013; Wickstrum et al., 2013). Finally, work
by the team of (Gérard et al., 2013) and more recently (Shima
et al., 2018) proved the efficacy of plasmid-based genetic tools on
C. pneumoniae (Gérard et al., 2013).
Chlamydia-Modified TargeTronTM
The evidence of transformable C. trachomatis opened up doors
to try modify pre-existing genetic engineering techniques for
use in Chlamydia. Johnson and Fisher therefore modified
the TargeTronTM technology for use in C. trachomatis. This
technology is based on the use of group II introns for targeted
insertional disruption of genes. None of these introns have
been described for Chlamydia but these do occur in ca. 25% of
bacterial genomes. There are known to move between genes via
a retrotransposition mechanism, regulated by an intron encoded
protein (IEP) that possesses RNA maturase, endonuclease, and
reverse transcriptase activity (Lambowitz and Zimmerly, 2004;
Johnson and Fisher, 2013). According to Johnson and Fisher, the
intron (designated as EBS2, EBS1, and δ) recognizes the sequence
of the target gene (designated as IBS2, IBS1, and δ’), after which it
inserts between the IBS1 and δ’ sites of the target gene. Although
insertion of the intron in DNA is a stable process, RNA transcripts
remain wild-type and no gene functions are lost due to the
splicing out of the intron from the RNA after transcription
(Johnson and Fisher, 2013). Perutka et al. (2004) proved that by
engineering the EBS1, EBS2, and δ intron sequences, the intron
Ll.LtrB from Lactococcus lactis can be targeted to new genes of
interest. Moreover, they showed that, by removing the Ll.LtrB IEP
gene from the intron and expressing it in trans, restorage of gene
function via post-transcriptional RNA splicing can be avoided.
Interestingly, by removing the IEP from the intron, room is
created for other genes such as selection cassettes. Perutka et al.
(2004) supplied Chlamydia with a plasmid that contained both
the intron and the IEP gene and subsequent expression of the
IEP enabled the insertion of the intron into a target gene. Next,
removal of the donor plasmid after intron insertion led to the
depletion of IEP and thus the prevention of intron splicing. By
consequence, the established intron insertions resulted in gene
inactivation (Perutka et al., 2004; Johnson and Fisher, 2013).
The latter principle later was marketed by Sigma, who called
it TargeTronTM technology. The TargeTronTM vector platform
was subsequently modified by Johnson and Fisher, who placed
a chlamydial promotor upstream of the intron and inserted an
ampicillin-resistance gene into the intron to allow for ampicillin
selection. As proof of principle in C. trachomatis, Johnson and
Fisher used the modified TargeTronTM technology to inactivate
the chromosomal gene, encoding IncA, the previously discussed
protein that regulates homotypic vesicle fusion. Cells, multiply
infected with the resulting IncA(-) mutants, demonstrated the
presence of non-fusogenic inclusions, as is also observed for
the naturally occurring mutants. Further proof of IncA knock-
down was provided by means of Western blotting (Johnson and
Fisher, 2013). Moreover, studies, using the insertion mutants in
well-established mouse infection models, proof the stability of
the intron insertion in an in vivo setting (Lowden et al., 2015).
In addition, successful insertion of an additional marker aadA,
a spectinomycin-resistance gene, in Chlamydia resulted in the
production of targeted double mutants and the ability to use gene
complementation (Lowden et al., 2015). However, despite the
promising results, specific insertional mutagenesis of genes at the
3′ end of operons is difficult because of the polar effects on the
operon. Moreover, the system is based on proprietary algorithms,
limiting integration to sites which are evaluated to be efficient.
Fluorescence-Reported Allelic Exchange
Mutagenesis (FRAEM)
Homologous recombination depends on a recombinant vector,
carrying the desired modifications. Introduction of this plasmid
in the cell results in the exchange of nucleotides with the genome.
Finally, elimination of the vector, now containing the original and
intact gene, is essential to obtain a change in the phenotype of the
cell (Binet and Maurelli, 2009). Binet and Maurelli were the first
to achieve the removal of a recombinant vector in Chlamydia.
They constructed a conditionally replicative plasmid by placing
pgp6, which is located on the native cryptic chlamydial plasmid
and controls plasmid maintenance and inheritance (Gong et al.,
2013; Song et al., 2013), under the control of an anhydrous
tetracycline (aTet)-inducible genetic circuit. Subsequently they
proved the efficacy of this conditionally replicative plasmid by
targeting and successfully exchanging C. trachomatis trpA for a
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2.2 Kb cassette, encoding both β-lactamase and green fluorescent
protein (GFP). This was achieved by flanking the cassette with 3
Kb of DNA that are homologous to the sequences upstream and
downstream of trpA. After allelic exchange, the absence of aTet
led to the elimination of the vector. Moreover, the introduction
and subsequent elimination of the vector could be observed in
real-time thanks to the presence of a mCherry gene on the vector
backbone. Successful introduction led to the presence of dual-
fluorescent transformants after which elimination of the vector
in the absence of aTet resulted in cells that were only positive
for GFP. Target versatility of FRAEM was studied by repeating
this technique for chlamydial genes ctl0063, ctl0064, and ctl0065.
Subsequent WGS on the resulting mutants proved the efficacy
and specificity of FREAM on Chlamydia (Mueller et al., 2016).
Floxed-Cassette Allelic Exchange
Mutagenesis
FRAEM enables chromosomal gene deletion by inserting a
selection cassette, which encodes antibiotic resistance and GFP.
However, as already mentioned, the insertion of cassettes in
polycistronic operons, which are common in the chlamydial
genome, could lead to polar effects. Indeed, FRAEM-mediated
deletion of Chlamydia trachomatis tmeA, a gene that is
transcribed as an operon with tmeB, negatively impacted the
expression of the latter (Mueller and Fields, 2015; McKuen et al.,
2017; Mueller et al., 2016). Therefore, Keb et al. (2018) adapted
FRAEM technology in order to create markerless gene deletions
by using a gfp-bla cassette, flanked by loxP sites; called the floxed
insertion cassette, in combination with transient production of
Cre by expression of the latter from a suicide plasmid pSUmC
template. Using the adapted FRAEM technology they succeeded
in generating a floxed-cassette tmeA C. trachomatis mutant.
Next, production of Cre led to the excision of the cassette, after
which Cre was depleted through curing of the suicide plasmid
encoding it. The latter was accomplished by cultivation under
non-selective conditions. As a result, the accomplished tmeA
mutant did express TmeB. Besides being useful in deletion studies
within polycistronic operons, these markerless gene deletions
limit artificial effects of a selectable marker on chlamydial fitness
and have the ability to excise large regions of chromosomal
DNA. The latter is very useful for characterizing the function
and contribution to virulence and tissue tropism of chromosomal
regions such as the highly polymorphic plasticity zones which
contain the previously discussed tryptophan biosynthesis genes,
or the family of expanded Pmp, also mentioned in this review
(Fehlner-Gardiner et al., 2002; Gomes et al., 2006; Keb et al., 2018;
Valdivia and Bastidas, 2018). Furthermore, this technique enables
the deletion of non-coding RNAs and small RNAs. Research on
these gene regulatory elements in Chlamydia is limited to date
(Valdivia and Bastidas, 2018).
CRISPRi
According to Ouellette: “one key tool missing from the
chlamydial genetic toolbox is the ability to create conditional
knock-outs of a target gene via inducible repression or other
means” (Ouellette, 2018). Since it is assumed that most of the
chlamydial genes are essential to the bacteria’s infection biology
because of the greatly reduced chlamydial genome, conditional
knock-outs are crucial in studying the function of these genes.
Therefore, recently, Ouellette described an innovative CRISPR
interference (CRISPRi) technique that uses the catalytically
inactive Cas9 variant (dCas9) of Staphylococcus aureus to
inducibly and reversibly repress gene expression in C. trachomatis
(Ouellette, 2018). CRISPRi is predicated on the ability of dCas9,
to recognize its cognate guide RNA and bind a target sequence
without cleaving it. If binding occurs near the 5′ end or in
the promoter region of a gene of interest, transcription will be
sterically hindered. Furthermore, by transforming cells with a
vector on which the expression of the guide RNA is constitutive
whilst the expression of dCas9 is controlled by an inducible
promoter, inducible knock-out of a specific target gene can be
achieved (Qi et al., 2013; Ouellette, 2018). Ouellette successfully
demonstrated the use of this single plasmid system for CRISPRi
in Chlamydia, targeting the expression of IncA (Ouellette, 2018).
CONCLUDING REMARKS
Although substantial knowledge is gathered on the molecular
host–pathogen interactions Chlamydiae employ in order to
survive and grow, it is clear that far from all pathways have
been fully characterized to date. For example, far from all
binding partners, involved in the attachment of the pathogen
to the host cell, have been identified yet. Furthermore, research
mainly focused on actin-dependent internalization of the
EB, thus data on actin-independent internalization is scarce.
Moreover, although numerous pathways to hijack host cell
metabolites have been described, a more detailed study on
these processes is necessary in order to fill in remaining
scientific gaps and discover new essential and/or redundant
pathways. Also, the understanding on the mechanism of
chlamydial release from infected host cells is limited. Since
the survival and proliferation of chlamydiae depends on all of
these selective interactions, more extensive knowledge hereof
would represent a powerful tool in the design or optimization
of antimicrobials and vaccines. Fortunately, recent advances in
the development of molecular genetic tools are enabling the
scientific community to start analyzing chlamydial infection
biology in more depth. By studying the chlamydial pathogenesis
and life cycle, prophylactic and therapeutic strategies to battle this
pathogen will gain efficiency.
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